GI
FATE icon

GAMMA Investing’s Fate Therapeutics FATE Stock Holding History

GAMMA Investing’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.96K Buy
1,467
+337
+30% +$624 ﹤0.01% 3569
2026
Q1 		$1.36K Buy
1,130
+908
+409% +$1.1K ﹤0.01% 3772
2025
Q4 		$218 Buy
+222
New +$267 ﹤0.01% 3993
2025
Q1 		– Sell
-626
Closed -$1.03K – 3825
2024
Q4 		$1.03K Sell
626
-135
-18% -$340 ﹤0.01% 3417
2024
Q3 		$2.66K Hold
761
– – ﹤0.01% 2975
2024
Q2 		$2.5K Sell
761
-32
-4% -$140 ﹤0.01% 2824
2024
Q1 		$5.82K Buy
793
+32
+4% +$198 ﹤0.01% 2340
2023
Q4 		$4.69K Buy
+761
New +$1.8K ﹤0.01% 2265

Other funds holding FATE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $454M AUM 31.05% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return